Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol etabonate ophthalmic gel versus vehicle after cataract surgery
2010-019246-11Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Postoperative ocular inflammation, post-operative ocular pain and cataract comparing Loteprednol etabonate ophthalmic gel 0.5% with Vehicle (2 arms). Primary endpoints: Hierarchical primary efficacy endpoints and Safety. Started Jun 2010; status: completed.
02
Drugs
loteprednol etabonate
03
Conditions
Postoperative ocular inflammationpost-operative ocular paincataract
Beyond the preview
Go deeper on 2010-019246-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019246-11.